Sight Sciences Financials - Benzinga

Sight Sciences Inc

SGHTNASDAQ

Trade with Public

Trade with Public

$8.07

0.020.25%

Dern. MÀJ: Sep 10, 12:50 PM

Aperçu Actualités Prévisions de résultats Événements Objectifs de coursDonnées financièresSentiment Actionnariat Comparer Options Rapport sur les stocks

Sight Sciences Financials

Sight Sciences (SGHT) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Sight Sciences Raises FY2026 Sales Guidance from $83.000M-$89.000M to $88.000M-$92.000M vs $86.083M Est

Sight Sciences (NASDAQ:SGHT) raises FY2026 sales outlook from $83.000 million-$89.000 million to $88.000 million-$92.000 million vs $86.083 million estimate.

Benzinga Newsdesk

PRO
Sight Sciences Q2 EPS $(0.08) Beats $(0.15) Estimate, Sales $23.388M Beat $21.682M Estimate

Sight Sciences (NASDAQ:SGHT) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.15) by 46.67 percent. This is a 65.22 percent increase over losses of $(0.23) per share from

Benzinga Newsdesk

Earnings Scheduled For May 6, 2026

Benzinga Insights

PRO
Sight Sciences Raises FY2026 Sales Guidance from $82.000M-$88.000M to $83.000M-$89.000M vs $84.695M Est

Sight Sciences (NASDAQ:SGHT) raises FY2026 sales outlook from $82.000 million-$88.000 million to $83.000 million-$89.000 million vs $84.695 million estimate.

Benzinga Newsdesk

PRO
Sight Sciences Q1 EPS $(0.24) Misses $(0.18) Estimate, Sales $19.700M Beat $18.544M Estimate

Sight Sciences (NASDAQ:SGHT) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.18) by 33.33 percent. This is a 14.29 percent increase over losses of $(0.28) per share from

Benzinga Newsdesk

Sight Sciences Q4 Earnings Assessment

Benzinga Insights

© 2026 Benzinga | All Rights Reserved